Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

BrightView Holdings shares declined 8.8% in premarket trading following lowered guidance for fiscal 2025. Shares were trading around $15.37. The stock is up 5.4% on the year.

Organon will discontinue its OG-6219 clinical-development program, after the investigational candidate failed to meet its primary efficacy endpoint in treating endometriosis-related pain.

CytoSorbents plans to ask Canadian health authorities to reconsider rejecting the company's license application for DrugSorb-ATR, an investigational device designed to reduce the severity of bleeding ...

A Deutsche Bank survey is asking investors what they're looking for on July 9, when a pause on the so-called reciprocal ...